We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Research Reports for Pepsi, UPS & Gilead Sciences
Read MoreHide Full Article
Friday, January 6 2016
Today's Research Daily features new research reports on 16 major stocks, including Gilead Sciences (GILD - Free Report) , Pepsi (PEP - Free Report) and United Parcel Services (UPS - Free Report) .
Gilead Sciences have been laggards lately, on persistent fears about drug pricing and other regulatory issues that haven't eased up even after the November election. The stock has lost -21% of its value over the last one year vs. the -17.4% decline for the Zacks Biotech industry in that same time period. Gilead's HCV franchise continues to witness slowdown in the U.S. and Europe due to lower sales of Harvoni. These challenges notwithstanding, but the analyst also points towards the company's robust late-stage pipeline. The company's HIV franchise has been performing well, thanks to the newly launched TAF-based products Genvoya, Descovy and Odefsey. (You can read the full research report on Gilead Sciences here >>)
Pepsi shares lagged the broader market last year (+7.3% for PEP vs. +16.1% for the S&P 500), but they outperformed the Zacks Soft Drinks Beverages industry as well as Coke (KO was +0.3%). The analyst emphasizes that Pepsi has been doing well on the back of continued momentum in the Frito-Lay business, revenue management strategies, improved productivity and better market execution. Moreover, Pepsi has been seeing higher volumes and profits in the North American region due to an improving economy, better industry pricing dynamics and a consistency in positive innovation. Pepsi reports Q4 results on February 9th. (You can read the full research report on Pepsi here >>)
UPS shares have been strong performers lately, up +24.4% in the past year. But the stock has lagged the Zacks Air Freight Industry (up +29.7%) as well as rival FedEx (up +40%). FedEx's Q4 report broadly offered favorable read-throughs for UPS's December-quarter results (it reports on January 31st), particularly with respect to volume trends over the holidays. The company's dominant ground operation positions it to be a beneficiary, along with FedEx, of the ongoing secular shift towards e-commerce. The company's strong cash flows and track record of returning excess cash to shareholders through dividends and buybacks is another positive. (You can read the full research report on United Parcel Services here >>)
Other noteworthy reports we are featuring today include Shell , Twitter and Stanley Black & Decker (SWK - Free Report) .
Today's Private Buys & Sells from Zacks Research While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weeklyEarnings TrendsandEarnings Previewreports. If you want an email notification each time Sheraz publishes a new article, pleaseclick here >>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Top Research Reports for Pepsi, UPS & Gilead Sciences
Friday, January 6 2016
Today's Research Daily features new research reports on 16 major stocks, including Gilead Sciences (GILD - Free Report) , Pepsi (PEP - Free Report) and United Parcel Services (UPS - Free Report) .
Gilead Sciences have been laggards lately, on persistent fears about drug pricing and other regulatory issues that haven't eased up even after the November election. The stock has lost -21% of its value over the last one year vs. the -17.4% decline for the Zacks Biotech industry in that same time period. Gilead's HCV franchise continues to witness slowdown in the U.S. and Europe due to lower sales of Harvoni. These challenges notwithstanding, but the analyst also points towards the company's robust late-stage pipeline. The company's HIV franchise has been performing well, thanks to the newly launched TAF-based products Genvoya, Descovy and Odefsey. (You can read the full research report on Gilead Sciences here >>)
Pepsi shares lagged the broader market last year (+7.3% for PEP vs. +16.1% for the S&P 500), but they outperformed the Zacks Soft Drinks Beverages industry as well as Coke (KO was +0.3%). The analyst emphasizes that Pepsi has been doing well on the back of continued momentum in the Frito-Lay business, revenue management strategies, improved productivity and better market execution. Moreover, Pepsi has been seeing higher volumes and profits in the North American region due to an improving economy, better industry pricing dynamics and a consistency in positive innovation. Pepsi reports Q4 results on February 9th. (You can read the full research report on Pepsi here >>)
UPS shares have been strong performers lately, up +24.4% in the past year. But the stock has lagged the Zacks Air Freight Industry (up +29.7%) as well as rival FedEx (up +40%). FedEx's Q4 report broadly offered favorable read-throughs for UPS's December-quarter results (it reports on January 31st), particularly with respect to volume trends over the holidays. The company's dominant ground operation positions it to be a beneficiary, along with FedEx, of the ongoing secular shift towards e-commerce. The company's strong cash flows and track record of returning excess cash to shareholders through dividends and buybacks is another positive. (You can read the full research report on United Parcel Services here >>)
Other noteworthy reports we are featuring today include Shell , Twitter and Stanley Black & Decker (SWK - Free Report) .
Today's Private Buys & Sells from Zacks Research
While we share the above news with the public, our sensitive recommendations are hidden from everyone but selected members. Would you like to peek behind the curtain and view them? Starting today, for the next month, you can follow all Zacks' private buys and sells in real time from value to momentum . . . from stocks under $10 to ETF and option moves . . . from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors. Click here for Zacks' secret trades >>
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>